+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome



Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome



American Journal of Medicine 118(11): 1287



The relationship between pyogenic vertebral osteomyelitis and infectious endocarditis is uncertain. This study investigates the incidence and risk factors of infectious endocarditis in patients with pyogenic vertebral osteomyelitis, and the outcome of pyogenic vertebral osteomyelitis with and without associated infectious endocarditis. A retrospective record review was conducted of all cases of vertebral osteomyelitis from January 1986 to June 2002, occurring in a tertiary referral hospital. Patients were followed for at least 6 months with careful attention to detection of infectious endocarditis and relapses. Among 606 patients with infectious endocarditis, 28 (4.6%) had pyogenic vertebral osteomyelitis. Among 91 cases of pyogenic vertebral osteomyelitis, 28 (30.8%) had infectious endocarditis. In 6 patients with no clinical signs of infectious endocarditis, the disease was established by routine echocardiography. Infectious endocarditis was more common in patients with predisposing heart conditions and streptococcal pyogenic vertebral osteomyelitis infection. Overall, pyogenic vertebral osteomyelitis in-hospital mortality was 11% (7.1% with infectious endocarditis). Twelve of 25 patients with infectious endocarditis with uncomplicated pyogenic vertebral osteomyelitis were treated for 4 to 6 weeks (endocarditis protocol), with no pyogenic vertebral osteomyelitis relapses. When specifically sought, the incidence of infectious endocarditis is high in patients with pyogenic vertebral osteomyelitis. Oral therapy may be an option for uncomplicated pyogenic vertebral osteomyelitis; nevertheless, in gram-positive infections, this approach should only be considered after excluding infectious endocarditis. Favorable outcome with shorter treatment in uncomplicated pyogenic vertebral osteomyelitis associated with infectious endocarditis suggests that prolonged therapy may not be needed in this subgroup except for those infected by difficult to treat microorganisms, such as methicillin-resistant Staphylococcus aureus or Candida spp.

(PDF emailed within 0-6 h: $19.90)

Accession: 050368618

Download citation: RISBibTeXText

PMID: 16271915

DOI: 10.1016/j.amjmed.2005.02.027


Related references

Outcome of culture-negative pyogenic vertebral osteomyelitis: comparison with microbiologically confirmed pyogenic vertebral osteomyelitis. Seminars in Arthritis and Rheumatism 44(2): 246-252, 2015

Risk factors and prognosis of vertebral compressive fracture in pyogenic vertebral osteomyelitis. Infection 44(1): 29-37, 2016

Long-term clinical and radiological magnetic resonance imaging outcome of abscess-associated spontaneous pyogenic vertebral osteomyelitis under conservative management. Seminars in Arthritis and Rheumatism 38(1): 28-40, 2007

Pyogenic vertebral osteomyelitis; manifestation of bacterial endocarditis. New York State Journal of Medicine 80(6): 980-982, 1980

Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case-control study. Medicine 96(21): E6387, 2017

Pyogenic Vertebral Column Osteomyelitis in Adults: Analysis of Risk Factors for 30-Day and 1-Year Mortality in a Single Center Cohort Study. Asian Spine Journal 2019, 2019

Spontaneous pyogenic vertebral osteomyelitis in nondrug users. Seminars in Arthritis and Rheumatism 31(4): 271-278, 2002

Management and outcome of pyogenic vertebral osteomyelitis. Clinical Orthopaedics and Related Research 1978(131): 160-167, 1978

Incidence and mortal risk factors of vertebral osteomyelitis. 2013

Vertebral osteomyelitis in paraplegia: incidence, risk factors, clinical picture. Journal of Spinal Cord Medicine 23(1): 15-22, 2000

Long-term outcome of pyogenic vertebral osteomyelitis: a cohort study of 260 patients. Open Forum Infectious Diseases 1(3): Ofu107, 2015

Diagnostic delay of pyogenic vertebral osteomyelitis and its associated factors. Scandinavian Journal of Rheumatology 46(1): 64-68, 2016

Pyogenic vertebral osteomyelitis: identification of microorganism and laboratory markers used to predict clinical outcome. European Spine Journal 19(4): 575-582, 2010

Factors associated with sequelae after treatment of hematogenous pyogenic vertebral osteomyelitis. Diagnostic Microbiology and Infectious Disease 2018, 2018

Incidence and risk factors for mortality of vertebral osteomyelitis: a retrospective analysis using the Japanese diagnosis procedure combination database. Bmj Open 3(3), 2013